Search for “7-OH ban” and you’ll find headlines that sound final. They aren’t. The federal process for 7-hydroxymitragynine (7-OH) has restarted with new proposed limits, and what matters to adult buyers sits in a few numbers most coverage skips. Below you’ll find what’s been proposed and when an order could realistically arrive. After that comes the practical part: what to check on products you already own.
Is 7-OH banned at the federal level right now?
No, not yet. The Justice Department’s October 9 update confirmed that DEA still hadn’t put out a temporary order covering 7-OH. What it described instead is a fresh notice of intent from DEA, one that pairs 7-OH with mitragynine pseudoindoxyl (MGPI) and rests on revised findings from Health and Human Services (HHS). This is DEA’s second run at it. The first notices of intent were announced on July 1, 2026.
MGPI is a separate story. Along with MGM-15 and MGM-16, it has sat on the temporary Schedule I list since August 26, 2026, according to the Federal Register notice published that day. DOJ says that control stays in force while DEA works through the new notice. So a product containing any of those three is already a federal problem, whatever happens with 7-OH.
Plain kratom leaf isn’t on any federal schedule. NCCIH, part of the National Institutes of Health, reports that DEA calls kratom a “drug of concern.” That phrase signals attention. It carries no scheduling force.
What would the proposed thresholds actually cover?
Two separate triggers came out of the HHS recommendation, and failing either one would be enough. The first is about concentration. A solid product crosses the line once 7-OH or MGPI by itself, or the two combined, goes past 1 mg in each gram. Liquids get the same number per milliliter. The second trigger is a ratio: if there’s less than 100 times as much mitragynine as 7-OH or MGPI (or the two together), the product would be covered even below the concentration limit.
None of this is final. DOJ framed the goal as separating products that have been deliberately enhanced or concentrated from products whose alkaloid mix looks like the botanical leaf. HHS found that 7-OH shows up in natural kratom only at relatively low levels. The FDA’s own figure puts 7-OH under 2% of the leaf’s total alkaloids.
In lab-report terms, 1 mg per gram means 0.1% by weight. Written in parts per million, it becomes 1,000. DEA’s July notice had set a lower bar for botanical material: more than 0.050% 7-OH on a dry weight basis, or half a milligram per gram. That July text had no ratio test at all.
When will the 7-OH ban start, if it happens?
Nobody can give you a start date yet, and anyone who does is guessing. What exists is a legal sequence. The Congressional Research Service (CRS) explains that 21 U.S.C. 811(h) requires DEA to publish its intent in the Federal Register no less than 30 days before temporary scheduling kicks in. The fresh notice carries docket number DEA-1570. It went on public inspection October 9 with a Federal Register publication date of October 14, 2026. Its own text rules out an order sooner than 30 days after that publication.
With publication set for October 14, no order can issue before November 13, 2026. Later is entirely possible. Under DEA’s July notice, an order becomes effective on its own Federal Register publication date. Buyers may get almost no lead time between seeing the order and being bound by it. CRS adds two details. A temporary order runs for as long as two years, and DEA can tack on one more year if it starts permanent scheduling. Courts also can’t review temporary scheduling decisions.
States aren’t waiting on DEA. Tennessee made kratom illegal across the state on July 1, 2026, through Matthew Davenport’s Law, whose definition sweeps in 7-OH plus synthetic equivalents on top of mitragynine. In California, the public health department has declared kratom and 7-OH products off-limits to make or sell for consumption, with seizures there topping $5 million. The Legislative Analysis and Public Policy Association’s January 2026 summary found kratom rules of some kind in 30 states plus DC.
Can you still comment, and where should you follow the notice?
Not in the usual sense. DEA isn’t inviting public comment on this notice. Its position is that temporary scheduling falls outside the Administrative Procedure Act’s notice-and-comment process. There was an earlier window, and CRS reports it was extended to September 10, 2026. It has since closed.
So following the record is what’s left. Start with the primary documents. That means the notice itself (docket DEA-1570 on federalregister.gov) plus each press release DOJ and DEA put out as steps happen. In the newest document, read the dates section first, because the earliest possible order date is printed there. If you’d like the timeline and key terms gathered in one place, 7OH.com’s scheduling explainer collects the earlier federal steps and the comment window that closed on September 10. Check its “last verified” date against the newest Federal Register entry, since it may not yet reflect the October notice, and do the same for any other secondary summary. This process has shifted more than once since July.
What should you check on 7-OH products you already have?
Pull up the certificate of analysis (COA) tied to the batch number on your package. A report labeled only with the product name says little about what you’re holding. Next, check which units the lab used. Some list percentages; others give mg per gram. Converting takes simple arithmetic, since one percent is ten milligrams in every gram, or 10,000 ppm. Measured that way, the proposed federal limit is one tenth of one percent.
A useful report puts mitragynine and 7-OH next to each other. Without both figures, nobody can run the proposed ratio test. A panel that shows 7-OH alone leaves that question open. Then look for “ND.” Labs print it when a result lands under their detection limit. ND isn’t a zero.
After that, scan for compounds that are already scheduled. Testing by the Center for Forensic Science Research and Education turned up MGM-15 inside products marketed under a long list of brand and blend names. A familiar name on the package proves nothing about the contents. Utah supplies a sharper example. Buzzers cat’s claw tablets turned out to contain kratom alkaloids, which prompted a July 30, 2026 warning from the Utah Department of Agriculture and Food together with the Utah Poison Control Center. Utah law also bars 7-OH above state limits, along with synthetic kratom-derived compounds.
Last, find out who ran the test. Testing labs earn accreditation under ISO/IEC 17025, so a report from a lab accredited to it, naming itself clearly, deserves more trust than an anonymous PDF. Listings deserve the same scrutiny. If you’re comparing 7-OH pills sold by a retailer, see whether each listing links to its own batch report. That report should give mitragynine and 7-OH in matching units, since the proposed rule turns on exactly those two numbers. A seller should also confirm you’re 21 or older.
What have federal health agencies said about safety?
Clean paperwork doesn’t make kratom or 7-OH safe, and it doesn’t confer approval either. According to the FDA, not a single kratom drug product has FDA approval. The agency classifies kratom as a new dietary ingredient lacking adequate safety information, a status that renders supplements containing it adulterated. Its consumer warning is blunt: don’t use kratom. Among the risks the FDA points to are liver toxicity and substance use disorder. On the chemistry, the FDA says 7-OH binds more tightly to mu-opioid receptors than mitragynine.
Enforcement against 7-OH sellers didn’t wait for scheduling. During 2025, FDA warning letters went to seven companies the agency accused of illegally distributing 7-OH products. HHS has also said the FDA’s attention is on 7-OH, not on natural kratom leaf.
Paperwork is the deciding factor during the notice period
Where I land: use the next 30 days to read paperwork, not as a buying deadline. If a seller can’t produce a batch COA with both mitragynine and 7-OH in mg per gram, I wouldn’t buy from them at all. But there’s an honest limit to this approach. A COA describes one batch on the day it was tested, and the final order could still differ from what HHS recommended. Your state may also make the federal question irrelevant. So check current state law first. Tennessee and California already prohibit sales outright.